Stephen Feider - 31 Jan 2025 Form 4 Insider Report for Beta Bionics, Inc. (BBNX)

Signature
/s/ Stephen Feider
Issuer symbol
BBNX
Transactions as of
31 Jan 2025
Net transactions value
$0
Form type
4
Filing time
03 Feb 2025, 20:30:08 UTC
Previous filing
29 Jan 2025
Next filing
03 Mar 2025

Key filing fact

Stephen Feider filed Form 4 for Beta Bionics, Inc. (BBNX) on 03 Feb 2025.

Key facts

  • This page summarizes Stephen Feider's Form 4 filing for Beta Bionics, Inc. (BBNX).
  • 3 reported transactions and 3 derivative rows are listed below.
  • Filing timestamp: 03 Feb 2025, 20:30.

Change

  • Previous filing in this sequence was filed on 29 Jan 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

BBNX transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+166,542
Change %
Price
$0.000000
Shares after
166,542
Date
31 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
166,542
Exercise price
$7.51
Footnotes
F1, F2
BBNX transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+109,695
Change %
Price
$0.000000
Shares after
109,695
Date
31 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
109,695
Exercise price
$5.10
Footnotes
F2, F3
BBNX transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+186,203
Change %
Price
$0.000000
Shares after
186,203
Date
31 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
186,203
Exercise price
$17.00
Footnotes
F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to this option shall vest one year after August 1, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.
F2 Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.
F3 The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
F4 Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .